Antagonizing Effects of Aspartic Acid against Ultraviolet A-Induced Downregulation of the Stemness of Human Adipose Tissue-Derived Mesenchymal Stem Cells

PLoS One. 2015 Apr 24;10(4):e0124417. doi: 10.1371/journal.pone.0124417. eCollection 2015.

Abstract

Ultraviolet A (UVA) irradiation is responsible for a variety of changes in cell biology. The purpose of this study was to investigate effects of aspartic acid on UVA irradiation-induced damages in the stemness properties of human adipose tissue-derived mesenchymal stem cells (hAMSCs). Furthermore, we elucidated the UVA-antagonizing mechanisms of aspartic acid. The results of this study showed that aspartic acid attenuated the UVA-induced reduction of the proliferative potential and stemness of hAMSCs, as evidenced by increased proliferative activity in the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and upregulation of stemness-related genes OCT4, NANOG, and SOX2 in response to the aspartic acid treatment. UVA-induced reduction in the mRNA level of hypoxia-inducible factor (HIF)-1α was also significantly recovered by aspartic acid. In addition, the antagonizing effects of aspartic acid against the UVA effects were found to be mediated by reduced production of PGE2 through the inhibition of JNK and p42/44 MAPK. Taken together, these findings show that aspartic acid improves reduced stemness of hAMSCs induced by UVA and its effects are mediated by upregulation of HIF-1α via the inhibition of PGE2-cAMP signaling. In addition, aspartic acid may be used as an antagonizing agent to mitigate the effects of UVA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue / cytology
  • Arabidopsis Proteins / genetics
  • Arabidopsis Proteins / metabolism
  • Aspartic Acid / pharmacology*
  • Cell Proliferation / drug effects
  • Cell Proliferation / radiation effects
  • Cells, Cultured
  • Cyclic AMP / biosynthesis
  • Dinoprostone / biosynthesis
  • Down-Regulation / drug effects
  • Down-Regulation / radiation effects
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / genetics
  • Intramolecular Transferases / genetics
  • Intramolecular Transferases / metabolism
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / radiation effects
  • Mesenchymal Stem Cells / drug effects*
  • Mesenchymal Stem Cells / metabolism
  • Mesenchymal Stem Cells / radiation effects*
  • Transcription Factor AP-1 / antagonists & inhibitors
  • Ultraviolet Rays / adverse effects*

Substances

  • Arabidopsis Proteins
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Transcription Factor AP-1
  • Aspartic Acid
  • Cyclic AMP
  • Intramolecular Transferases
  • marneral synthase, Arabidopsis
  • Dinoprostone

Grants and funding

This study was supported by a grant from the Korean Health Technology R & D Project, Ministry of Health and Welfare, Republic of Korea (Grant Number: HN13C0072). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Kwangseon Jung is employed by Skincure Life Science Institute. Skincure Life Science Institute provided support in the form of salary for author KJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the ‘author contributions’ section. Co-author Eunsun Jung is employed by Biospectrum Life Science Institute. Biospectrum Life Science Institute provided support in the form of salary for author EJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.